trial · primary record
Amivantamab IV
Advanced or Metastatic Colorectal Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 225 |
| Primary completion | 2031-05-11 |
| Primary endpoint | Cohorts A, B, and C: Objective Response Rate (ORR) |
| Registry ID | NCT05379595 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:46.817Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05379595
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Amivantamab IV · compound